Detalles de la búsqueda
1.
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle.
Biochem J
; 456(1): 119-28, 2013 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23937259
2.
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.
J Neurochem
; 116(2): 304-15, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21073465
3.
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Circulation
; 114(6): 565-73, 2006 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-16880329
4.
Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.
Circulation
; 112(8): 1136-44, 2005 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16103240
5.
In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2.
Front Mol Neurosci
; 7: 51, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24917786
6.
Metabolic labeling of leucine rich repeat kinases 1 and 2 with radioactive phosphate.
J Vis Exp
; (79): e50523, 2013 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084685
7.
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.
PLoS One
; 7(8): e43472, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22952686
Resultados
1 -
7
de 7
1
Próxima >
>>